S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › CYL › Research report
← CYL page
XStocksXray
Market X-Ray report · 19 October 2026

Catalyst Metals Ltd (CYL)

Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026

Key indicators

Last closeAUD 5.550
52-week range4.480 – 9.800
Return, 1 month / 3 months−18.1% / −6.3%
Return, 1 year / 3 years−26.0% / +753.8%
TrendBelow its 200-day average
RSI (14)43
Volatility (1 year)68.6%
Worst drawdown (1 year)-51.0%
Average daily value traded9.55M AUD
Dividend yield–

Market X-Ray price-based

60/ 100 · High confidence · ahead of 63% of stocks on this exchange
Trend53
Momentum52
Stability (higher is calmer)55
Liquidity92
Income–

Five-year price chart navy: price · brown: 200-day average

-0.092.485.057.6210.192021-102023-012024-042025-072026-10

About the company

Catalyst Metals is an Australian gold producer and explorer. The company operates underground gold mines in Western Australia and Tasmania, where it extracts and processes ore to produce gold doré and concentrate. It also explores for gold across its project areas in Victoria and Western Australia. Its activities span mining, processing and exploration, with output refined and then passed on to precious-metals markets. The company is based in Australia and its securities trade on the Australian Securities Exchange.

Catalyst Metals Ltd trades under the code CYL on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Catalyst Metals Ltd (CYL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 5.550 on 19 October 2026.

Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 665 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 26.0% and over the last three months it fell 6.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Catalyst Metals Ltd (CYL)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend53 · FairMixed trend against its averages.
Above 200-day average-13.8%
From 52-week high-42.4%
Momentum52 · FairTypical recent returns for this exchange.
3-month return-6.3%
6-month return-15.1%
12-month return, skipping the last month-9.6%
Stability (higher is calmer)55 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)68.6%
Worst drawdown, 1 year (smaller is calmer)-51.0%
Liquidity92 · StrongTrades actively.
Average daily value traded9.55M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week−2.1%
1 month−18.1%
3 months−6.3%
6 months−15.1%
1 year−26.0%
3 years+753.8%
5 years+165.6%

Signals

50-day / 200-day average6.256 / 6.437
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.271

Technical summary

DailyStrongly bearish1 bullish · 4 neutral · 11 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026